Literature DB >> 23444478

Improved facial nerve outcomes using an evolving treatment method for large acoustic neuromas.

Ryan G Porter1, Michael J LaRouere, Jack M Kartush, Dennis I Bojrab, Daniel R Pieper.   

Abstract

OBJECTIVE: To describe a successful paradigm for the treatment of large acoustic neuromas (vestibular schwannomas). STUDY
DESIGN: Retrospective case review.
SETTING: Tertiary referral center. PATIENTS: The charts of 2,875 acoustic neuroma patients at Michigan Ear Institute were reviewed to identify 153 patients who underwent surgical resection for large acoustic neuromas (>=3 cm) between 2000 and 2009. INTERVENTION(S): Staged surgical resection or single stage surgery with or without adjuvant stereotactic radiosurgery. MAIN OUTCOME MEASURE(S): Postoperative facial nerve outcomes are reported using the House-Brackmann (HB) facial nerve grading scale and compared with historical controls from a literature review. Rates of adverse outcomes are also reported.
RESULTS: Seventy-five patients underwent staged surgical resection of their tumors, whereas 78 patients underwent either single stage surgery or surgery with subsequent stereotactic radiosurgery. Eighty-one percent of patients in the staged surgical resection group had a postoperative HB Grade I or II facial nerve function compared with 75% in the single stage surgical group. Overall, 78% of patients in the current study had HB Grade I or II after treatment compared with a mean of 53% in the literature for similar sized tumors. Our methods including the decision to use staged surgery when necessary, dissection of tumor with stimulating dissector-directed intraoperative monitoring, and use of adjuvant stereotactic radiosurgery are described.
CONCLUSION: Using the described paradigm, large acoustic neuromas can be successfully treated with either staged or single-stage surgical resection with or without adjuvant radiosurgery to obtain more favorable facial nerve outcomes than historically reported controls while minimizing morbidity for the patient. (C) 2013 Otology & Neurotology, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23444478     DOI: 10.1097/mao.0b013e31827d07d4

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  5 in total

1.  Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) Practice Guideline.

Authors:  May N Tsao; Arjun Sahgal; Wei Xu; Antonio De Salles; Motohiro Hayashi; Marc Levivier; Lijun Ma; Roberto Martinez; Jean Régis; Sam Ryu; Ben J Slotman; Ian Paddick
Journal:  J Radiosurg SBRT       Date:  2017

2.  Influencing Factors Analysis of Facial Nerve Function after the Microsurgical Resection of Acoustic Neuroma.

Authors:  WenMing Hong; HongWei Cheng; XiaoJie Wang; ChunGuo Feng
Journal:  J Korean Neurosurg Soc       Date:  2017-03-01

3.  Contemporary Opinions on Intraoperative Facial Nerve Monitoring.

Authors:  Paul W Gidley; Jennifer Maw; Bruce Gantz; David Kaylie; Paul Lambert; Sonya Malekzadeh; Sujana S Chandrasekhar
Journal:  OTO Open       Date:  2018-08-07

4.  Surgical management for large vestibular schwannomas: a systematic review, meta-analysis, and consensus statement on behalf of the EANS skull base section.

Authors:  Daniele Starnoni; Lorenzo Giammattei; Giulia Cossu; Michael J Link; Pierre-Hugues Roche; Ari G Chacko; Kenji Ohata; Majid Samii; Ashish Suri; Michael Bruneau; Jan F Cornelius; Luigi Cavallo; Torstein R Meling; Sebastien Froelich; Marcos Tatagiba; Albert Sufianov; Dimitrios Paraskevopoulos; Idoya Zazpe; Moncef Berhouma; Emmanuel Jouanneau; Jeroen B Verheul; Constantin Tuleasca; Mercy George; Marc Levivier; Mahmoud Messerer; Roy Thomas Daniel
Journal:  Acta Neurochir (Wien)       Date:  2020-07-29       Impact factor: 2.216

5.  Facial nerve function and hearing after microsurgical removal of sporadic vestibular schwannomas in a population-based cohort.

Authors:  Ismail Taha; Antti Hyvärinen; Antti Ranta; Olli-Pekka Kämäräinen; Jukka Huttunen; Esa Mervaala; Heikki Löppönen; Tuomas Rauramaa; Antti Ronkainen; Juha E Jääskeläinen; Arto Immonen; Nils Danner
Journal:  Acta Neurochir (Wien)       Date:  2019-09-07       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.